Search

everythinglearnresearchcommunity

for

Search:↓

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

Cellular and immunotherapies show promise for healing chronic wounds but need more research.

Skin side effects from cancer treatments can lead to changes in therapy and are common, with nail changes being the most frequent.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

9-cis-retinoic acid showed some effectiveness in treating AIDS-related Kaposi sarcoma but had significant side effects at higher doses.

Natural compounds, especially Withaferin-A, may help treat post-COVID-19 complications, but some may have side effects.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.

Different species and human skin models vary in their skin enzyme activities, with pig skin and some models closely matching human skin, useful for safety assessments and understanding the skin's protective roles.

AHCC reduces hair loss and liver injury caused by chemotherapy in rodents.

Scientists developed a new method to deliver alopecia treatment directly to hair follicles, which could be a promising treatment for hair loss and other hair diseases.

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

Some drugs can cause rare but potentially deadly skin reactions, and early treatment and avoiding the drug again are key.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Nanotechnology improves hair care products by enhancing ingredient stability, targeting treatment, and reducing side effects, but more research on its toxicity is needed.

The study developed a tool to predict how gut microbes process foods and drugs, showing that similar compounds often share metabolic pathways and effects.

Gene therapy shows promise for enhancing physical traits but faces ethical, safety, and regulatory challenges.

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

Electric pulse treatments for breast cancer show promise in being safer and more effective, with fewer side effects.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Air pollution worsens skin diseases and aging by causing inflammation and oxidative stress.

Toxic epidermal necrolysis is a severe skin reaction often linked to drugs, requiring careful medication use and supportive care.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

The document provides advice on how to recognize and treat skin-related side effects of cancer drugs known as EGFR inhibitors.

EGFR inhibitors can cause yellowish skin eruptions.

Atorvastatin reversed memory problems caused by cancer drug trastuzumab and improved its cancer-fighting abilities without causing hair loss.

An emollient PLUS balm with ADE-G1 significantly improved skin dryness and quality of life in cancer patients with xerosis.